tiprankstipranks
Advertisement
Advertisement
Sana Biotechnologies: Mayo Collaboration and HIP Platform Progress Reinforce Buy Rating and Unchanged $7 Price Target
PremiumRatingsSana Biotechnologies: Mayo Collaboration and HIP Platform Progress Reinforce Buy Rating and Unchanged $7 Price Target
3M ago
Frahm Initiates Buy on Sana Biotechnology, Citing Differentiated In Vivo CAR‑T Pipeline and Strong Cash Runway into 2027
Premium
Ratings
Frahm Initiates Buy on Sana Biotechnology, Citing Differentiated In Vivo CAR‑T Pipeline and Strong Cash Runway into 2027
3M ago
Sana Biotechnology reports Q1 non-GAAP EPS (14c), consensus (15c)
Premium
The Fly
Sana Biotechnology reports Q1 non-GAAP EPS (14c), consensus (15c)
3M ago
Sana Biotechnology price target raised to $7 from $6 at Wedbush
PremiumThe FlySana Biotechnology price target raised to $7 from $6 at Wedbush
4M ago
Sana Biotechnology: Mayo Clinic Collaboration and UP421 Data De‑Risk SC451 and Support Buy Rating on Type 1 Diabetes Momentum
Premium
Ratings
Sana Biotechnology: Mayo Clinic Collaboration and UP421 Data De‑Risk SC451 and Support Buy Rating on Type 1 Diabetes Momentum
4M ago
Sana Biotechnology Secures Strategic Equity Investment from Mayo
Premium
Company Announcements
Sana Biotechnology Secures Strategic Equity Investment from Mayo
4M ago
AI Adoption Exposes Sana Biotechnology to Rising Data, Compliance, and Reputational Risks
PremiumCompany AnnouncementsAI Adoption Exposes Sana Biotechnology to Rising Data, Compliance, and Reputational Risks
5M ago
Sana Biotechnology: Emerging Clinical Validation and 2026 Pivotal Milestones Underpin Buy Rating
Premium
Ratings
Sana Biotechnology: Emerging Clinical Validation and 2026 Pivotal Milestones Underpin Buy Rating
5M ago
Sana Biotechnology files automatic mixed securities shelf
Premium
The Fly
Sana Biotechnology files automatic mixed securities shelf
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100